Urinary Findings and Biomarkers in Autosomal Dominant Polycystic Kidney Disease

被引:0
作者
Kocyigit, Ismail [1 ]
Eroglu, Eray [1 ]
Ecder, Tevfik [2 ]
机构
[1] Erciyes Univ, Div Nephrol, Sch Med, Kayseri, Turkey
[2] Istanbul Bilim Univ, Div Nephrol, Sch Med, Istanbul, Turkey
来源
TURKISH JOURNAL OF NEPHROLOGY | 2020年 / 29卷 / 01期
关键词
Polycystic kidney disease; biomarkers; urine; GELATINASE-ASSOCIATED LIPOCALIN; RENAL CONCENTRATING CAPACITY; FRIZZLED-RELATED PROTEIN; FETUIN-A; NEPHROTIC SYNDROME; CYST INFECTION; PROGRESSION; VASOPRESSIN; INJURY; NEPHROLITHIASIS;
D O I
10.5152/turkjnephrol.2020.3554
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Autosomal dominant polycystic kidney disease (ADPKD), characterized by the development of multiple cysts in the kidneys and other organs, is the most common hereditary renal disorder and the fourth leading cause of end-stage renal disease. In adults with a positive family history, the diagnosis of ADPKD is made based on the radiologic evidence of bilateral, fluid-filled renal cysts. Furthermore, initial symptoms including pain, increased thirst, polyuria, nocturia, and increased urinary frequency may lead to the diagnosis of ADPKD. An easily accessible, applicable, and cost-effective biomarker is needed to predict the clinical course of ADPKD due to its progressive pattern. Urine is an easily obtainable and widely used test specimen for diagnosis and follow-up in several renal diseases. Thus, the aim of the present study was to review and assess new urinary biomarkers and urinary findings in ADPKD.
引用
收藏
页码:66 / 76
页数:11
相关论文
共 115 条
[1]  
Ahmed ER, 2006, SAUDI J KIDNEY DIS T, V17, P511
[2]   A family with a milder form of adult dominant polycystic kidney disease not linked to the PKD1 (16p) or PKD2 (4q) genes [J].
Ariza, M ;
Alvarez, V ;
Marin, R ;
Aguado, S ;
LopezLarrea, C ;
Alvarez, J ;
Menendez, MJ ;
Coto, E .
JOURNAL OF MEDICAL GENETICS, 1997, 34 (07) :587-589
[3]   Pain management in polycystic kidney disease [J].
Bajwa, ZH ;
Gupta, S ;
Warfield, CA ;
Steinman, TI .
KIDNEY INTERNATIONAL, 2001, 60 (05) :1631-1644
[4]   Renal volume measurements: Accuracy and repeatability of US compared with that of MR imaging [J].
Bakker, J ;
Olree, M ;
Kaatee, R ;
de Lange, EE ;
Moons, KGM ;
Beutler, JJ ;
Beek, FJA .
RADIOLOGY, 1999, 211 (03) :623-628
[5]   Urine proteome of autosomal dominant polycystic kidney disease patients [J].
Magda Bakun ;
Mariusz Niemczyk ;
Dominik Domanski ;
Radek Jazwiec ;
Anna Perzanowska ;
Stanislaw Niemczyk ;
Michal Kistowski ;
Agnieszka Fabijanska ;
Agnieszka Borowiec ;
Leszek Paczek ;
Michal Dadlez .
Clinical Proteomics, 2012, 9 (1)
[6]   Angiogenesis in autosomal-dominant polycystic kidney disease [J].
Bello-Reuss, E ;
Holubec, K ;
Rajarman, S .
KIDNEY INTERNATIONAL, 2001, 60 (01) :37-45
[7]   Urine MicroRNA as Potential Biomarkers of Autosomal Dominant Polycystic Kidney Disease Progression: Description of miRNA Profiles at Baseline [J].
Ben-Dov, Iddo Z. ;
Tan, Ying-Cai ;
Morozov, Pavel ;
Wilson, Patricia D. ;
Rennert, Hanna ;
Blumenfeld, Jon D. ;
Tuschl, Thomas .
PLOS ONE, 2014, 9 (01)
[8]   Wnt signaling in polycystic kidney disease [J].
Benzing, Thomas ;
Simons, Matias ;
Walz, Gerd .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2007, 18 (05) :1389-1398
[9]   RENAL EXCRETION AND CYST ACCUMULATION OF BETA-2MICROGLOBULIN IN POLYCYSTIC KIDNEY-DISEASE [J].
BIRENBOIM, N ;
DONOSO, VS ;
HUSEMAN, RA ;
GRANTHAM, JJ .
KIDNEY INTERNATIONAL, 1987, 31 (01) :85-92
[10]   Copeptin, a surrogate marker for vasopressin, is associated with kidney function decline in subjects with autosomal dominant polycystic kidney disease [J].
Boertien, Wendy E. ;
Meijer, Esther ;
Zittema, Debbie ;
van Dijk, Marjan A. ;
Rabelink, Ton J. ;
Breuning, Martijn H. ;
Struck, Joachim ;
Bakker, Stephan J. L. ;
Peters, Dorien J. M. ;
de Jong, Paul E. ;
Gansevoort, Ron T. .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (11) :4131-4137